Dupixent Pushes Sanofi's Quarterly Sales Past $14.5 Billion Mark

Sanofi SA

Sanofi SA (NASDAQ:SNY) reported third-quarter sales of $14.55 billion (12.43 billion euros), beating the consensus of $14.46 billion. Sales increased 2.3% year over year, up 7% in constant currency.

U.S. sales were 6.84 billion euros, up 11.1%, primarily driven by Immunology, pharma launches, and Lantus, partly offset by vaccines.